ATE334982T1 - 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- - Google Patents

7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-

Info

Publication number
ATE334982T1
ATE334982T1 AT01972861T AT01972861T ATE334982T1 AT E334982 T1 ATE334982 T1 AT E334982T1 AT 01972861 T AT01972861 T AT 01972861T AT 01972861 T AT01972861 T AT 01972861T AT E334982 T1 ATE334982 T1 AT E334982T1
Authority
AT
Austria
Prior art keywords
enantiomer
pyridylethyl
hydroxy
pain
chlorine
Prior art date
Application number
AT01972861T
Other languages
English (en)
Inventor
Dean Gordon Brown
Rebecca Ann Urbanek
Megan Murphy
Wenhua Xiao
Frances Marie Mclaren
Edward Vacek
Thomas Bare
Carey Lynn Horchler
Christine Barlaam
Gary Banks Steelman
Vernon Alford
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE334982T1 publication Critical patent/ATE334982T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01972861T 2000-09-29 2001-09-28 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- ATE334982T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23663000P 2000-09-29 2000-09-29

Publications (1)

Publication Number Publication Date
ATE334982T1 true ATE334982T1 (de) 2006-08-15

Family

ID=22890309

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01972861T ATE334982T1 (de) 2000-09-29 2001-09-28 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-

Country Status (7)

Country Link
US (1) US6933297B2 (de)
EP (1) EP1325003B1 (de)
JP (1) JP2004509964A (de)
AT (1) ATE334982T1 (de)
AU (1) AU2001292499A1 (de)
DE (1) DE60121978D1 (de)
WO (1) WO2002026740A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002026741A1 (en) * 2000-09-29 2002-04-04 Astrazeneca Ab 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN
US20090015991A1 (en) * 2004-06-09 2009-01-15 Maik Hyrenbach Gas-Insulated Switchgear Assembly Having An Inspection Window For Visually Detecting The Switching Position Of The Switching Contacts
CA2689137C (en) * 2007-05-29 2017-05-02 Intrexon Corporation Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
RU2711968C1 (ru) * 2018-11-22 2020-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский национальный исследовательский политехнический университет" Анальгезирующее средство

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9420590D0 (en) * 1993-10-22 1994-11-30 Zeneca Ltd Pyridazino quinoline compounds
GB9507318D0 (en) 1995-04-07 1995-05-31 Zeneca Ltd Alpha substituted pyridazino quinoline compounds
EP1244453A1 (de) 1999-12-23 2002-10-02 AstraZeneca AB Verfahren und zusammensetzung zur behandlung von schmerzen
US20030153571A1 (en) * 1999-12-23 2003-08-14 Brown Dean Gordon Method and composition for the treatment of pain
WO2002026741A1 (en) * 2000-09-29 2002-04-04 Astrazeneca Ab 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN

Also Published As

Publication number Publication date
JP2004509964A (ja) 2004-04-02
AU2001292499A1 (en) 2002-04-08
US6933297B2 (en) 2005-08-23
US20040053930A1 (en) 2004-03-18
EP1325003B1 (de) 2006-08-02
EP1325003A1 (de) 2003-07-09
DE60121978D1 (de) 2006-09-14
WO2002026740A1 (en) 2002-04-04

Similar Documents

Publication Publication Date Title
BG106095A (bg) Нови лекарствени състави на базата на антихолинергично активни съединения и бета-миметици
GEP20053602B (en) Aripiprazole for Oral Administration
CZ309247B6 (cs) 40-O-(2-hydroxyethyl)rapamycin pro použití jako jediná účinná látka při léčení solidního nádoru
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
BR0211305A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
BR9510168A (pt) Composto poliaminoácido composição forma unitária de dosagem e método par epreparar uma composição
BRPI0108977B8 (pt) compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
BR0109703A (pt) Derivados de piperazina
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
DK0840601T3 (da) THIP til behandling af søvnforstyrrelser
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
ATE412646T1 (de) Zur behandlung von schmerzen geeignete therapeutische mittel
SE9802208D0 (sv) Novel compounds
DK0699439T3 (da) Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
ATE253359T1 (de) Antithrombotische mittel
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
ATE334982T1 (de) 7-chlor-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-
SE9802209D0 (sv) Novel compounds
BG105434A (bg) Сертралинов орален концентрат

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties